ScreenerHero

MBX Microbix Biosystems Inc.

TSX · CA · Healthcare · Biotechnology · microbix.com
0.3000CAD0.00%Mkt Cap: 29.92M $P/E: —

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company m…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.24BUSDP/E 29.3
REGN
Regeneron Pharmaceuticals, Inc.
$76.05BUSDP/E 18.3
MRNA
Moderna, Inc.
$74.84BUSD
ARGX
argenx SE
$56.77BUSDP/E 37.1
ARGX
argenx SE
$58.21BUSDP/E 35.5
UCB
UCB SA
$41.93BUSDP/E 17.9
RVMD
Revolution Medicines, Inc.
$42.84BUSD
ONC
BeOne Medicines AG
$41.27BUSDP/E 64.9
RPRX
Royalty Pharma plc
$32.61BUSDP/E 30.0
ALNY
Alnylam Pharmaceuticals, Inc.
$29.97BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.66BUSD
BNTX
BioNTech SE
$24.05BUSD
GMAB
Genmab A/S
$23.24BUSDP/E 29.8
INSM
Insmed Incorporated
$22.98BUSD
GMAB
Genmab A/S
$22.23BUSDP/E 30.6
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
JAZZ
Jazz Pharmaceuticals plc
$15.02BUSDP/E 15.9
ASND
Ascendis Pharma A/S
$14.87BUSDP/E 17.3
EXEL
Exelixis, Inc.
$14.45BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$13.81BUSD

Key Statistics

Company
Market Cap29.92M USD
Enterprise Value29.60M USD
Revenue (TTM)11.22M USD
Gross Profit7.18M USD
Net Income (TTM)-1.64M USD
Revenue/Share0.11 CAD
Last Price0.3000 CAD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)15.00
PEG—
EV/EBITDA-13.30
EV/Revenue2.64
P/S2.67
P/B1.69
EPS (TTM)-0.04
EPS (Forward)0.02
52W Range
0.210082% of range0.3200
52W High0.3200 CAD
52W Low0.2100 CAD
Profitability
Gross Margin53.02%
Oper. Margin-16.21%
EBITDA Margin-19.84%
Profit Margin-12.08%
ROE-8.08%
ROA-6.00%
Growth
Revenue Growth16.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-58.47K USD
CapEx (TTM)580.64K USD
FCF Margin-18.50%
FCF Yield-6.93%
Net Debt-320.48K USD
Net Debt/EBITDA0.14
Balance Sheet
Debt/Equity0.24
Current Ratio6.89
Quick Ratio3.17
Book Value/Sh0.18 CAD
Cash/Share0.05 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield142.46%
Payout Ratio0.00%
Ex-Div DateSep 2, 1999
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.4000 CAD
Upside (mean)+33.3%
Target Range0.4000 CAD – 0.4000 CAD
# Analysts1
Ownership
Shares Out.136.97M
Float114.04M
Insiders14.86%
Institutions0.00%
Short Interest
Short Ratio1.0d
Short % Out.0.02%
Shares Short28.79K
Short (prev mo.)31.63K
Technical
SMA 500.3022 (-0.7%)
SMA 2000.2660 (+12.8%)
Beta0.57
S&P 52W Chg14.58%
Avg Vol (30d)32.34K
Avg Vol (10d)15.50K
Technical Indicators
RSI (14)49.0
MACD0.0006
MACD Signal0.0008
MACD Hist.-0.0002
BB Upper0.3179 CAD
BB Middle0.3005 CAD
BB Lower0.2831 CAD
BB Width11.61%
ATR (14)0.0103 CAD
Vol Ratio (20d)4.47x